Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous platelet activating factor does not affect lung epithelial permeability.

J W Bloom1, S F Quan, M Halonen

  • 1Division of Respiratory Sciences, University of Arizona College of Medicine, Tucson 85724.

Research Communications in Chemical Pathology and Pharmacology
|December 1, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cough during infancy and subsequent childhood asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2015
Same author

The effect of antireflux treatment on the frequency of awakenings from sleep in patients with Gastroesophageal reflux disease.

Neurogastroenterology and motility·2014
Same author

The penetration of antibacterial substances into ischemic, inflammatory tissue; with a consideration of their use in shock of bacterial origin.

The American journal of the medical sciences·2010
Same author

Increased oesophageal acid exposure at the beginning of the recumbent period is primarily a recumbent-awake phenomenon.

Alimentary pharmacology & therapeutics·2010
Same author

Relation of early antibiotic use to childhood asthma: confounding by indication?

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2010
Same author

Riser's reflux--an eye-opening experience.

Neurogastroenterology and motility·2010
Same journal

Is heat acclimation able to increase whole-body sensitivity to insulin?

Research communications in chemical pathology and pharmacology·1994
Same journal

Vasodilator effects of clonidine on the mesenteric arterial beds in normotensive and spontaneously hypertensive rats.

Research communications in chemical pathology and pharmacology·1994
Same journal

Elevation of ceruloplasmin activity involved in changes of hepatic metal concentration in primary biliary cirrhosis.

Research communications in chemical pathology and pharmacology·1994
Same journal

Copper cytotoxicity impairs DNA synthesis but not protein phosphorylation upon growth stimulation in LEC mutant rat.

Research communications in chemical pathology and pharmacology·1994
Same journal

Enhanced sensitivity of mdx mice to intramuscular injection of compound 48/80.

Research communications in chemical pathology and pharmacology·1994
Same journal

Inhibition of antigen-induced airway hyperresponsiveness in rats: effects of ozagrel (a thromboxane A2 synthase inhibitor) and of CV-3988 (a platelet activating factor antagonist).

Research communications in chemical pathology and pharmacology·1994
See all related articles

This study investigated whether the substance platelet activating factor, known to cause fluid buildup in the lungs, does so by damaging the barrier between the air sacs and the bloodstream. Researchers measured how quickly a tracer molecule moved from the lungs into the blood after injecting the factor. While the substance caused significant changes in blood pressure and cell activity, it did not speed up the movement of the tracer. The findings suggest that fluid accumulation caused by this factor occurs through mechanisms other than increasing the permeability of the lung lining.

Area of Science:

  • Respiratory physiology within pulmonary medicine
  • Platelet activating factor signaling in vascular biology

Background:

The mechanisms underlying pulmonary fluid accumulation remain incompletely understood in various mammalian models. Prior research has shown that systemic delivery of certain lipid mediators induces significant lung edema. That uncertainty drove investigators to examine whether these substances directly alter the integrity of the alveolar barrier. No prior work had resolved if this specific lipid mediator increases the passage of solutes across the lung lining. It was already known that such agents trigger profound hemodynamic shifts and inflammatory cell recruitment. This gap motivated a closer look at the functional state of the pulmonary epithelium during exposure. Understanding these pathways is necessary for clarifying how different substances disrupt lung fluid balance. These observations provide a foundation for distinguishing between hydrostatic and permeability-related edema.

Purpose Of The Study:

The aim of this investigation was to determine if the lipid mediator increases the permeability of the alveolar epithelium in the rabbit. Researchers sought to clarify the mechanism behind the known ability of this substance to cause pulmonary edema. The study addressed whether fluid accumulation results from direct damage to the lung barrier or from other systemic effects. This objective was motivated by the need to distinguish between different types of lung injury. The team examined if the substance alters the movement of solutes across the air-blood interface. By measuring tracer clearance, they intended to quantify any changes in the functional state of the epithelium. This work addresses the uncertainty regarding how systemic inflammatory agents influence lung fluid balance. The researchers aimed to provide a definitive assessment of the role of permeability in this specific pathological process.

Keywords:
pulmonary edemalung physiologyvascular permeabilitylipid mediators

Frequently Asked Questions

The researchers propose that the substance triggers fluid buildup through hemodynamic shifts rather than by increasing the barrier permeability. This conclusion follows from the observation that the clearance rate of the tracer remained unchanged despite systemic administration of the lipid mediator.

The study utilized 99mTc-DTPA, a radioactive tracer molecule, to assess the integrity of the alveolar-capillary barrier. This specific compound is commonly used to measure the rate at which solutes move from the air spaces into the bloodstream.

The rabbit model was chosen because prior evidence indicated that this species develops significant pulmonary edema when exposed to the lipid mediator. This animal model allows for the assessment of both hemodynamic responses and epithelial barrier function in a controlled environment.

Related Experiment Videos

Main Methods:

Review Approach involved evaluating the impact of systemic lipid mediator delivery on pulmonary barrier integrity in a rabbit model. The investigation focused on quantifying the movement of a radioactive tracer across the lung lining. Researchers administered the substance intravenously to observe its physiological consequences. They monitored hemodynamic changes and cellular activity to ensure the agent was biologically active. The team measured the rate of tracer disappearance from the lungs into the blood over a specific timeframe. This approach allowed for a direct assessment of whether the barrier became more porous. The experimental design ensured that systemic responses were captured while isolating the effect on epithelial function. This methodology provided a robust framework for testing the hypothesis regarding fluid accumulation mechanisms.

Main Results:

Key Findings From the Literature demonstrate that the lipid mediator failed to increase the clearance of the tracer from the lungs. The rate of movement for the radioactive marker remained consistent with baseline values despite the administration of the substance. The researchers observed marked hemodynamic and cellular responses, confirming the systemic efficacy of the treatment. These results indicate that the barrier function of the alveolar lining was preserved during the experiment. The data show no significant difference in solute transport between the treated group and control subjects. This finding contradicts the expectation that all edema-inducing agents necessarily disrupt the integrity of the lung lining. The study provides quantitative evidence that the substance does not alter the permeability of the alveolar epithelium. These observations suggest that fluid buildup in this model occurs independently of changes to the barrier.

Conclusions:

Synthesis and Implications suggest that while this lipid mediator promotes fluid retention, it does not directly compromise the alveolar barrier. The authors propose that the observed edema arises from hemodynamic alterations rather than epithelial damage. These findings clarify that increased solute clearance is not a required feature of this specific pathological response. The researchers emphasize that the barrier remains intact despite systemic exposure to the substance. This work highlights the importance of differentiating between vascular pressure effects and structural barrier failure. The evidence indicates that the lung lining maintains its functional integrity during the acute phase of this reaction. These results offer a clearer picture of how systemic inflammatory mediators influence pulmonary fluid dynamics. The study confirms that permeability changes are not the primary cause of fluid buildup in this experimental model.

The researchers tracked the clearance of the radioactive tracer from the lungs to the blood to quantify barrier function. This data type provides a direct measurement of how effectively the alveolar epithelium prevents the movement of small molecules into the circulation.

The team monitored hemodynamic and cellular responses alongside the tracer clearance. These measurements confirmed that the systemic effects of the substance were active, even though the permeability of the alveolar lining did not change.

The authors state that the substance does not produce an acute increase in the permeability of the alveolar epithelium. This finding implies that fluid accumulation in this context is likely driven by factors other than structural damage to the lung lining.